Cancer Research Meeting Calendar  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 1245-1252, March 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalgo, M. L.
Right arrow Articles by Jones, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalgo, M. L.
Right arrow Articles by Jones, P. A.

The Role of DNA Methylation in Expression of the p19/p16 Locus in Human Bladder Cancer Cell Lines1

Mark L. Gonzalgo, Toshiro Hayashida, Christina M. Bender, Martha M. Pao, Yvonne C. Tsai, Felicidad A. Gonzales, Hung D. Nguyen, TuDung T. Nguyen and Peter A. Jones2

Department of Biochemistry and Molecular Biology, Urologic Cancer Research Laboratory, USC/Norris Comprehensive Cancer Center, University of Southern California, School of Medicine, Los Angeles, California 90033

Methylation of CpG sites in the control regions of tumor suppressor genes may be an important mechanisms for their heritable, yet reversible, transcriptional inactivation. These changes in methylation may impair the proper expression and/or function of cell cycle regulatory genes and confer a selective growth advantage to affected cells. Detailed methylation analysis using genomic bisulfite sequencing was performed on a series of subclones of a bladder cancer cell line in which a hypermethylated p16 gene had been reactivated by transient treatment with 5-aza-2'-deoxycytidine. Methylation of the CpG island in the promoter of the p16 gene in human bladder cancer cells did not stop the formation of a transcript initiated 20 kb upstream by the p19 promoter but did prevent the expression of a p16 transcript. Furthermore, we show that reactivant clones that expressed p16 at varying levels contained heterogeneous methylation patterns, suggesting that p16 expression can occur even in the presence of a relatively heavily methylated coding region. We also present the first functional evidence that methylation of only a small number of CpG sites can significantly down-regulate p16 promoter activity, thus providing support for the model of progressive inactivation of this tumor suppressor gene by DNA methylation.

1 This work was supported by USPHS Grants 5 R35 CA49758 and 5 U01 CA70903 from the National Cancer Institute.

2 To whom requests for reprints should be addressed, at USC/Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Room 815, Mail Stop #83, Los Angeles, CA 90033. Phone: (213) 764-0816; Fax: (213) 764-0102.

Received 6/27/97. Accepted 1/16/98.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A. Paya, C. Alenda, L. Perez-Carbonell, E. Rojas, J.-L. Soto, C. Guillen, A. Castillejo, V. M. Barbera, A. Carrato, A. Castells, et al.
Utility of p16 Immunohistochemistry for the Identification of Lynch Syndrome
Clin. Cancer Res., May 1, 2009; 15(9): 3156 - 3162.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
H. Tang and E. Goldberg
Homo sapiens Lactate Dehydrogenase c (Ldhc) Gene Expression in Cancer Cells Is Regulated by Transcription Factor Sp1, CREB, and CpG Island Methylation
J Androl, March 1, 2009; 30(2): 157 - 167.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
Y. Tang, A. R. Simoneau, J. Xie, B. Shahandeh, and X. Zi
Effects of the Kava Chalcone Flavokawain A Differ in Bladder Cancer Cells with Wild-type versus Mutant p53
Cancer Prevention Research, November 1, 2008; 1(6): 439 - 451.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Woloszynska-Read, P. Mhawech-Fauceglia, J. Yu, K. Odunsi, and A. R. Karpf
Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer
Clin. Cancer Res., June 1, 2008; 14(11): 3283 - 3290.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Yamada, Y. Nishida, H. Tsutsumida, T. Hamada, M. Goto, M. Higashi, M. Nomoto, and S. Yonezawa
MUC1 Expression Is Regulated by DNA Methylation and Histone H3 Lysine 9 Modification in Cancer Cells
Cancer Res., April 15, 2008; 68(8): 2708 - 2716.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Weichart, J. Gobom, S. Klopfleisch, R. Hasler, N. Gustavsson, S. Billmann, H. Lehrach, D. Seegert, S. Schreiber, and P. Rosenstiel
Analysis of NOD2-mediated Proteome Response to Muramyl Dipeptide in HEK293 Cells
J. Biol. Chem., January 27, 2006; 281(4): 2380 - 2389.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Fatemi, M. M. Pao, S. Jeong, E. N. Gal-Yam, G. Egger, D. J. Weisenberger, and P. A. Jones
Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level
Nucleic Acids Res., November 27, 2005; 33(20): e176 - e176.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. C. Chuang, C. B. Yoo, J. M. Kwan, T. W.H. Li, G. Liang, A. S. Yang, and P. A. Jones
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine
Mol. Cancer Ther., October 1, 2005; 4(10): 1515 - 1520.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
K. Miyamoto and T. Ushijima
Diagnostic and Therapeutic Applications of Epigenetics
Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 293 - 301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Deb-Rinker, D. Ly, A. Jezierski, M. Sikorska, and P. R. Walker
Sequential DNA Methylation of the Nanog and Oct-4 Upstream Regions in Human NT2 Cells during Neuronal Differentiation
J. Biol. Chem., February 25, 2005; 280(8): 6257 - 6260.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Abe, M. Ohira, A. Kaneda, Y. Yagi, S. Yamamoto, Y. Kitano, T. Takato, A. Nakagawara, and T. Ushijima
CpG Island Methylator Phenotype Is a Strong Determinant of Poor Prognosis in Neuroblastomas
Cancer Res., February 1, 2005; 65(3): 828 - 834.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Chan, J. E. Fish, C. D'Abreo, S. Lin, G. B. Robb, A.-M. Teichert, F. Karantzoulis-Fegaras, A. Keightley, B. M. Steer, and P. A. Marsden
The Cell-specific Expression of Endothelial Nitric-oxide Synthase: A ROLE FOR DNA METHYLATION
J. Biol. Chem., August 13, 2004; 279(33): 35087 - 35100.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Liang, J. C. Y. Lin, V. Wei, C. Yoo, J. C. Cheng, C. T. Nguyen, D. J. Weisenberger, G. Egger, D. Takai, F. A. Gonzales, et al.
Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome
PNAS, May 11, 2004; 101(19): 7357 - 7362.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Hisano, H. Ohta, Y. Nishimune, and M. Nozaki
Methylation of CpG dinucleotides in the open reading frame of a testicular germ cell-specific intronless gene, Tact1/Actl7b, represses its expression in somatic cells
Nucleic Acids Res., August 15, 2003; 31(16): 4797 - 4804.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
T. Ushijima, N. Watanabe, E. Okochi, A. Kaneda, T. Sugimura, and K. Miyamoto
Fidelity of the Methylation Pattern and Its Variation in the Genome
Genome Res., May 1, 2003; 13(5): 868 - 874.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. C. Cheng, C. B. Matsen, F. A. Gonzales, W. Ye, S. Greer, V. E. Marquez, P. A. Jones, and E. U. Selker
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
J Natl Cancer Inst, March 5, 2003; 95(5): 399 - 409.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. S. Tam, T. R. Devereux, A. C. Patel, J. F. Foley, R. R. Maronpot, and T. E. Massey
Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors
Carcinogenesis, January 1, 2003; 24(1): 121 - 132.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. Berggren, R. Kumar, S. Sakano, L. Hemminki, T. Wada, G. Steineck, J. Adolfsson, P. Larsson, U. Norming, H. Wijkstrom, et al.
Detecting Homozygous Deletions in the CDKN2A(p16INK4a)/ARF(p14ARF) Gene in Urinary Bladder Cancer Using Real-Time Quantitative PCR
Clin. Cancer Res., January 1, 2003; 9(1): 235 - 242.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Tada, M. Wada, K.-i. Taguchi, Y. Mochida, N. Kinugawa, M. Tsuneyoshi, S. Naito, and M. Kuwano
The Association of Death-associated Protein Kinase Hypermethylation with Early Recurrence in Superficial Bladder Cancers
Cancer Res., July 15, 2002; 62(14): 4048 - 4053.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
V. J. Mutskov, C. M. Farrell, P. A. Wade, A. P. Wolffe, and G. Felsenfeld
The barrier function of an insulator couples high histone acetylation levels with specific protection of promoter DNA from methylation
Genes & Dev., June 15, 2002; 16(12): 1540 - 1554.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Velicescu, D. J. Weisenberger, F. A. Gonzales, Y. C. Tsai, C. T. Nguyen, and P. A. Jones
Cell Division Is Required for de Novo Methylation of CpG Islands in Bladder Cancer Cells
Cancer Res., April 1, 2002; 62(8): 2378 - 2384.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. W. Y. Chan, L. W. Chan, N. L. S. Tang, J. H. M. Tong, K. W. Lo, T. L. Lee, H. Y. Cheung, W. S. Wong, P. S. F. Chan, F. M. M. Lai, et al.
Hypermethylation of Multiple Genes in Tumor Tissues and Voided Urine in Urinary Bladder Cancer Patients
Clin. Cancer Res., February 1, 2002; 8(2): 464 - 470.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. T. Nguyen, F. A. Gonzales, and P. A. Jones
Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation
Nucleic Acids Res., November 15, 2001; 29(22): 4598 - 4606.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. Nguyen, G. Liang, T. T. Nguyen, D. Tsao-Wei, S. Groshen, M. Lubbert, J.-H. Zhou, W. F. Benedict, and P. A. Jones
Susceptibility of Nonpromoter CpG Islands to De Novo Methylation in Normal and Neoplastic Cells
J Natl Cancer Inst, October 3, 2001; 93(19): 1465 - 1472.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Hyun Song, H.-S. Jong, H. H. Choi, H. Inoue, T. Tanabe, N. K. Kim, and Y.-J. Bang
Transcriptional Silencing of Cyclooxygenase-2 by Hyper-methylation of the 5' CpG Island in Human Gastric Carcinoma Cells
Cancer Res., June 1, 2001; 61(11): 4628 - 4635.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Magdinier and A. P. Wolffe
Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia
PNAS, April 12, 2001; (2001) 101617298.
[Abstract] [Full Text]


Home page
GutHome page
H Kaneto, S Sasaki, H Yamamoto, F Itoh, M Toyota, H Suzuki, I Ozeki, N Iwata, T Ohmura, T Satoh, et al.
Detection of hypermethylation of the p16INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus
Gut, March 1, 2001; 48(3): 372 - 377.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Zheng, P. Chen, A. McMillan, A. Lafuente, M. J. Lafuente, A. Ballesta, M. Trias, and J. K. Wiencke
Correlations of partial and extensive methylation at the p14ARF locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors
Carcinogenesis, November 1, 2000; 21(11): 2057 - 2064.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. C. Patel, C. H. Anna, J. F. Foley, P. S. Stockton, F. L. Tyson, J.C. Barrett, and T. R. Devereux
Hypermethylation of the p16 Ink4a promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines
Carcinogenesis, September 1, 2000; 21(9): 1691 - 1700.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. A. Eads, R. V. Lord, S. K. Kurumboor, K. Wickramasinghe, M. L. Skinner, T. I. Long, J. H. Peters, T. R. DeMeester, K. D. Danenberg, P. V. Danenberg, et al.
Fields of Aberrant CpG Island Hypermethylation in Barrett's Esophagus and Associated Adenocarcinoma
Cancer Res., September 1, 2000; 60(18): 5021 - 5026.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
H. Kinoshita, Y. Shi, C. Sandefur, L. F. Meisner, C. Chang, A. Choon, C. R. Reznikoff, G. S. Bova, A. Friedl, and D. F. Jarrard
Methylation of the Androgen Receptor Minimal Promoter Silences Transcription in Human Prostate Cancer
Cancer Res., July 1, 2000; 60(13): 3623 - 3630.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. Sarkar, K. P. Jülicher, M. S. Burger, V. Della Valle, C.-J. Larsen, T. R. Yeager, T. B. Grossman, R. W. Nickells, C. Protzel, D. F. Jarrard, et al.
Different Combinations of Genetic/Epigenetic Alterations Inactivate the p53 and pRb Pathways in Invasive Human Bladder Cancers
Cancer Res., July 1, 2000; 60(14): 3862 - 3871.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
D. G. Farwell, K. A. Shera, J. I. Koop, G. A. Bonnet, C. P. Matthews, G. W. Reuther, M. D. Coltrera, J. K. McDougall, and A. J. Klingelhutz
Genetic and Epigenetic Changes in Human Epithelial Cells Immortalized by Telomerase
Am. J. Pathol., May 1, 2000; 156(5): 1537 - 1547.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. H. N. Wong, M. H. L. Ng, D. P. Huang, and J. C. K. Lee
Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications
Blood, March 15, 2000; 95(6): 1942 - 1949.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Milutinovic, J. D. Knox, and M. Szyf
DNA Methyltransferase Inhibition Induces the Transcription of the Tumor Suppressor p21WAF1/CIP1/sdi1
J. Biol. Chem., February 25, 2000; 275(9): 6353 - 6359.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. P. Pogribny, M. Pogribna, J. K. Christman, and S. J. James
Single-Site Methylation within the p53 Promoter Region Reduces Gene Expression in a Reporter Gene Construct: Possible in Vivo Relevance during Tumorigenesis
Cancer Res., February 1, 2000; 60(3): 588 - 594.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
K. Nosaka, M. Maeda, S. Tamiya, T. Sakai, H. Mitsuya, and M. Matsuoka
Increasing Methylation of the CDKN2A Gene Is Associated with the Progression of Adult T-Cell Leukemia
Cancer Res., February 1, 2000; 60(4): 1043 - 1048.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S. J. Frost, D. J. Simpson, R. N. Clayton, and W. E. Farrell
Transfection of an Inducible p16/CDKN2A Construct Mediates Reversible Growth Inhibition and G1 Arrest in the AtT20 Pituitary Tumor Cell Line
Mol. Endocrinol., November 1, 1999; 13(11): 1801 - 1810.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
C. M. Bender, M. L. Gonzalgo, F. A. Gonzales, C. T. Nguyen, K. D. Robertson, and P. A. Jones
Roles of Cell Division and Gene Transcription in the Methylation of CpG Islands
Mol. Cell. Biol., October 1, 1999; 19(10): 6690 - 6698.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. P. Xing, Y. Nie, Y. Song, G.-Y. Yang, Y. C. Cai, L.-D. Wang, and C. S. Yang
Mechanisms of Inactivation of p14ARF, p15INK4b, and p16INK4a Genes in Human Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., October 1, 1999; 5(10): 2704 - 2713.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. E. Cameron, S. B. Baylin, and J. G. Herman
p15INK4B CpG Island Methylation in Primary Acute Leukemia Is Heterogeneous and Suggests Density as a Critical Factor for Transcriptional Silencing
Blood, October 1, 1999; 94(7): 2445 - 2451.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Rein, T. Kobayashi, M. Malott, M. Leffak, and M. L. DePamphilis
DNA Methylation at Mammalian Replication Origins
J. Biol. Chem., September 3, 1999; 274(36): 25792 - 25800.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. J. Wong, S. A. Foster, D. A. Galloway, and B. J. Reid
Progressive Region-Specific De Novo Methylation of the p16 CpG Island in Primary Human Mammary Epithelial Cell Strains during Escape from M0 Growth Arrest
Mol. Cell. Biol., August 1, 1999; 19(8): 5642 - 5651.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. F. Jarrard, S. Sarkar, Y. Shi, T. R. Yeager, G. Magrane, H. Kinoshita, N. Nassif, L. Meisner, M. A. Newton, F. M. Waldman, et al.
p16/pRb Pathway Alterations Are Required for Bypassing Senescence in Human Prostate Epithelial Cells
Cancer Res., June 1, 1999; 59(12): 2957 - 2964.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. E. Lantry, Z. Zhang, K. A. Crist, Y. Wang, G. J. Kelloff, R. A. Lubet, and M. You
5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model
Carcinogenesis, February 1, 1999; 20(2): 343 - 346.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. D. Robertson and P. A. Jones
The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53
Mol. Cell. Biol., November 1, 1998; 18(11): 6457 - 6473.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Magdinier and A. P. Wolffe
Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia
PNAS, April 24, 2001; 98(9): 4990 - 4995.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.